Early surgical intervention for fulminant pseudomembranous colitis

American Surgeon

Volumn 74, Issue 1, 2008, Pages 20-26

  Ali, Syed O ^a   Welch, John P ^b,c,d,e,j   Dring, Robert J ^f,g,h,i  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Department of Surgery   (United States)

^c HARTFORD HOSPITAL   (United States)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

^f NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^g LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^h ST FRANCIS HOSPITAL   (United States)

ⁱ WINTHROP UNIVERSITY HOSPITAL   (United States)

^j NONE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFUROXIME; CLINDAMYCIN; HYPERTENSIVE FACTOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COLON RESECTION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMODYNAMICS; HUMAN; LEUKOCYTE COUNT; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PSEUDOMEMBRANOUS COLITIS; SURVIVAL; CLOSTRIDIUM DIFFICILE; DECISION TREE; FOLLOW UP; MIDDLE AGED; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; COLECTOMY; DECISION TREES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 40749117283     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Lipsett PA, Samantaray DK, Tam ML, et al. Pseudomembranous colitis: A surgical disease? Surgery 1994;116:491-6.
2. Hall IC, O' Toole E. Intestinal flora in newborn infants with a description of new pathological anaerobe. Bacillus diffilis. Am J Dis Child 1935;49:390-402.
3. Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978;298:531-4.
4. Barbut F, Petit J-C. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 2001;7:405-10.
5. Jobe BA, Grasley A, Deveney KE, et al. Clostridium difficile colitis: An increasing hospital-acquired illness. Am J Surg 1995;169:480-3.
6. Hurley BW, Nguyen CC. Spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 2002;162:2177-84.
7. Pepin J, Valiquett L, Alary M, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003; a changing pattern of disease severity. JAMC 2004;171:466-72.
8. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-41.
9. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9.
10. Synott K, Mealy K, Merry C, et al. Timing of surgery for fulminating pseudomembranous colitis. Br J Surg 1998;85:229-31.
11. Dallal RM, Harbrecht DG, Boujouksd AJ, et al. Fulminant Clostridium difficile: An underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363-72.
12. Kent KG, Rubin MS, Wroblewski L, et al. The impact of Clostridium difficile on a surgical service. Ann Surg 1998;227:296-301.
13. Frei R. Cases of Clostridium difficile colitis on the rise nationwide. Gen Surg News 2006;2:21.
14. Bradbury AW, Barrett S. Surgical aspects of Clostridium difficile colitis. Br J Surg 1997;84:150-9.
15. Poxton IR, McCoubrey J, Blair G. The pathogenicity of Clostridium difficile. Clin Microbiol Infect 2001;7:421-7.
16. Dial S, Delaney JAC, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989-95.
17. Slotwiner-Nie PK, Brandt LJ. Infectious diarrhea in the elderly. Gastroenterol Clin North Am 2001;30:625-35.
18. Kyne L, Warny M, Qamar A, Kelly CP. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhea. Lancet 2001;357:189-93.
19. Nair S, Yadav D, Corpuz M, Pitchumon CS. Clostridium difficile colitis: Factors influencing treatment failure and relapse-prospective evaluation. Am J Gastroenterol 1998;93:1873-6.
20. Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhea. Arch Intern Med 2001;161:525-33.
21. Aslam S, Hamill RJ, Musher DM. Treatment of Clostridium difficile-associated disease: Old therapies and new strategies. Lancet Infect Dis 2005;5:549-57.
22. Apisarnthanarak A, Razavi B, Mundy LM. Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: Case series and review of the literature. Clin Infect Dis 2002;35:690-6.
23. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: Treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002;97:1769-75.
24. McPherson S, Rees CJ, Ellis R, et al. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum 2006;49:640-5.
25. McFarland LV. Alternative treatments for Clostridium difficile disease: What really works? J Med Microbiol 2005;54:101-11.
26. Morris AM, Jobe BA, Stoney M, et al. Clostridium difficile colitis. An increasingly aggressive iatrogenic disease? Arch Surg 2002;137:1096-100.
27. Rosenberg JM, Walker M, Welch JP, Mullany L. Clostridium difficile colitis in surgical patients. Am J Surg 1984;147:486-91.
28. Wistrom J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhea in 2462 antibiotic-treated hospitalized patients: A prospective study. J Antimicrob Chemother 2001;47:43-50.
29. Pendergast TM, Marini CP, D'Angelo AJ, et al. Surgical patients with pseudomembranous colitis: Factors affecting prognosis. Surgery 1994;116:768-75.
30. Klipfel AA, Schein M, Fahoum B, Wise L. Acute abdomen and Clostridium difficile colitis: Still a lethal combination. Dig Surg 2000;17:160-3.
31. Koss K, Clark MA, Sanders DS, et al. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis 2006;8:149-54.
32. Murray PR, Barron EJ, Pfaller MA, et al., eds. Manual of Clinical Microbiology, 6th ed. Washington, DC: ASM Press, 1995.
33. Kirkpatrick ADC, Greenberg HM. Evaluating the CT diagnosis of Clostridium difficile colitis: Should CT guide therapy? AJR Am J Roentgenol 2001;176:635-9.
34. O'Sullivan SG. The accordion sign. Radiology 1998;206:177-8.
35. Panis Y, Hautefeuille P, Hecht Y, et al. Surgical treatment of toxic megacolon complicating pseudomembranous colitis. Apropos of a case, review of the literature. Ann Surg 1992;46:453-7.
36. Marinella MA, Burdette SD, Bedimo R, Markert RJ. Leukemoid reactions complicating colitis due to Clostridium difficile. South Med J 2004;97:959-63.
37. Bradley SJ, Weaver DW, Maxwell NPT, Bouwman DL. Surgical management of pseudomembranous colitis. Am Surg 1998;54:329-32.
38. Medich DS, Lee KK, Simmons RL, et al. Laparotomy for fulminant pseudomembranous colitis. Arch Surg 1992;127:847-52.
39. Viswanath YKS, Griffiths CDM. The role of surgery in pseudomembranous enterocolitis. Postgrad Med J 1998;74:216-9.
40. Schnitt SJ, Antonioli DA, Goldman H. Massive mural edema in severe pseudomembranous colitis. Arch Pathol Lab Med 1983;107:211-3.
41. Trudel JL, Deschenes M, Mayrand S, Barkun AN. Toxic megacolon complicating pseudomembranous enterocolitis. Dis Colon Rectum 1995;38:1033-8.